• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Global Fund and Siemens Healthineers to accelerate adoption of AI for TB diagnosis

, 28 November 2023/in E-News /by panglobal

Siemens Healthineers and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), announced a partnership at the recent World Health Summit to accelerate the use of artificial intelligence (AI) in X-ray screening for tuberculosis (TB), a preventable, treatable, and curable infectious disease that is again on the rise globally.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/11/peter-sands-scaled.jpg 1707 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-11-28 18:52:512023-11-28 18:52:51Global Fund and Siemens Healthineers to accelerate adoption of AI for TB diagnosis

4D Lifetec secures $26m investment from Xlife Sciences to open new horizons in early cancer detection

, 28 November 2023/in E-News /by panglobal

In a significant financial milestone, Xlife Sciences has invested CHF23.3 million (US$26,3 million) in 4D Lifetec, acquiring a 20% stake in the company. With the agreement, Xlife Sciences is not only bringing in a direct cash investment, but also an AI software developed specifically for 4D Lifetec, which will massively expand the functionality of the […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/11/4D-Lifetec.jpg 945 1203 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-11-28 18:23:222023-11-28 18:23:224D Lifetec secures $26m investment from Xlife Sciences to open new horizons in early cancer detection

SOPHiA GENETICS enters collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to address global inequalities in cancer care

, 28 November 2023/in E-News /by panglobal

SOPHiA GENETICS, a global leader in data-driven medicine will collaborate with Memorial Sloan Kettering Cancer Center (MSK), a top cancer treatment and research institution, and AstraZeneca to advance health equity on a global scale by providing inclusive access to comprehensive cancer testing worldwide.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-11-28 18:20:222023-11-28 18:20:22SOPHiA GENETICS enters collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to address global inequalities in cancer care

Belfast Health and Social Care Trust and Siemens Healthineers announce 20-year Value Partnership

, 28 November 2023/in E-News /by panglobal

Royal Victoria Hospital (RVH), part of Belfast Health and Social Care Trust, and Siemens Healthineers have announced a multi-million-euro, 20-year agreement to streamline clinical workflows and boost patient care across Belfast and surrounding areas in Northern Ireland. In addition to equipment management, this Value Partnership contains elements such as programmes for clinical services optimization and […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/11/belfast-health.png 1800 2400 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-11-28 18:18:442023-11-28 18:18:44Belfast Health and Social Care Trust and Siemens Healthineers announce 20-year Value Partnership

Owlstone Medical starts recruiting patients in Phase 2 clinical trial for the early detection of lung cancer through breath biopsy

, 28 November 2023/in E-News /by panglobal

Owlstone Medical, a pioneer in breath biopsy for applications in early disease detection and precision medicine, has begun recruitment of patients into its EVOLUTION Phase 2 clinical trial following successful achievement of key safety and proof of concept milestones in Phase 1. The trial has been designed to support development of a breath test to […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/11/owlstone_breath_biopsy.jpg 1232 1172 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-11-28 18:15:022023-11-28 18:15:02Owlstone Medical starts recruiting patients in Phase 2 clinical trial for the early detection of lung cancer through breath biopsy

ScreenPoint Medical Hits New Milestones

, 21 November 2023/in E-News /by panglobal

World’s Leading Breast AI Software, Transpara Surpasses 5 Million Mammograms and 1 Million Tomosynthesis Studies Analyzed to Support Radiologists Reading Mammograms

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/11/ScreenPoint_Medical_Logo.jpg 146 400 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-11-21 10:38:452023-11-21 10:38:45ScreenPoint Medical Hits New Milestones

Spinal cord neuroprosthesis helps person with Parkinson’s disease walk again

, 15 November 2023/in E-News /by panglobal

Neuroscientists and neurosurgeons at the EPFL/CHUV/UNIL, Inserm and the University of Bordeaux have designed a neuroprosthetic intended to correct walking disorders associated with Parkinson’s disease. In a study published in Nature Medicine, the scientists set out in detail the process of developing the neuroprosthetic that has allowed a first patient with Parkinson’s to be treated, […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/11/Scherm­afbeelding-2023-11-15-om-17.04.13.png 760 1352 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-11-15 16:13:012023-11-15 16:13:01Spinal cord neuroprosthesis helps person with Parkinson’s disease walk again

International Hospital Federation (IHF) announces winners of IHF Awards 2023

, 27 October 2023/in E-News /by panglobal

On 26 October 2023, the IHF held its annual Award Ceremony and Gala Dinner to celebrate excellence in hospital and healthcare leadership.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/10/2023-IHF-AWARDS_image.jpg 1278 1704 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-10-27 17:40:422023-10-27 17:40:42International Hospital Federation (IHF) announces winners of IHF Awards 2023

ESAOTE’s new S-scan Open redefines excellence in magnetic resonance imaging

, 27 October 2023/in E-News /by panglobal

Esaote, a leading Italian company in ultrasound, dedicated MRI and healthcare IT, presents S-scan Open, the new configuration of S-scan, one of its best-selling MRI systems.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/10/ESAOTE_new_MRI_system.jpg 267 400 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-10-27 17:32:592023-10-27 17:32:59ESAOTE’s new S-scan Open redefines excellence in magnetic resonance imaging

Aidoc Expands its Partnership with GLEAMER to Enhance its Chest Imaging AI Suite

, 18 October 2023/in E-News /by panglobal

GLEAMER’s ChestView solution strengthens Aidoc’s capabilities to meet the rising demand for chest imaging amidst a radiology workforce crisis across Europe. Aidoc, the leading provider of healthcare AI solutions, announced a partnership expansion with GLEAMER, a leading European MedTech company pioneering the use of AI technology in the practice of radiology, to integrate their ChestView […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2023/10/Aidoc_Always_On_AI_Logo.jpg 160 400 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2023-10-18 11:03:582023-10-18 11:18:21Aidoc Expands its Partnership with GLEAMER to Enhance its Chest Imaging AI Suite
Page 25 of 231«‹2324252627›»

Latest issue of International Hospital

April 2024

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

27 June 2025

GE HealthCare advances cardiac PET diagnostics with Flyrcado launch

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription